Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update – secondary publication
Modern Rheumatology · 28.03.2024 · 34 (3) · 559-567
DOI: 10.1093/mr/road081 ↗Kurz gefasst
Leitlinie in der Zeitschrift Modern Rheumatology, online erschienen am 28.07.2023. Verfasst von Ken-Ei Sada und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Ome Municipal General Hospital, Ome, Japan. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Objective
To revise the 2017 clinical practice guidelines (CPG) for the management of microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) to reflect advancements in the field.
Methods
Similar to the 2017 CPG, the Grading of Recommendations, Assessment, Development, and Evaluation system was adopted for this revision. The intended users of this CPG include patients diagnosed with MPA or GPA in Japan and their families and healthcare professionals, including specialists and non-specialists. Based on a scoping review, four clinical questions (CQs) of the 2017 guidelines were modified, and six new CQs were added.
Results
We suggest a combination of glucocorticoid and cyclophosphamide or rituximab for remission induction therapy. In cases where cyclophosphamide or rituximab is used, we suggest the use of avacopan over high-dose glucocorticoid. Furthermore, we suggest against the use of plasma exchange in addition to the standard treatment in severe cases of MPA/GPA. Finally, we suggest the use of glucocorticoid and rituximab over glucocorticoid and azathioprine for remission maintenance therapy.
Conclusions
The recommendations have been updated based on patient preference, certainty of evidence, benefit and risk balance, and cost.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Ome Municipal General Hospital, Ome, Japan.
- Department of Rheumatology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
- Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Tokyo, Japan.
- Department of Family Medicine, Seibo International Catholic Hospital, Tokyo, Japan.
- Department of Otolaryngology-Head & Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
- Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan.
ORCID-Profile: Ken-Ei Sada
Zitieren
APA
Sada, K. E., Nagasaka, K., Kaname, S., Nango, E., Kishibe, K., Dobashi, H., Hiromura, K., Kawakami, T., Bando, M., Wada, T., Amano, K., Murakawa, Y., & Harigai, M. (2024). Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update – secondary publication. Modern Rheumatology, 34(3), 559-567. https://doi.org/10.1093/mr/road081
Vancouver
Sada KE, Nagasaka K, Kaname S, Nango E, Kishibe K, Dobashi H, et al. Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update – secondary publication. Modern Rheumatology. 2024;34(3):559-567. doi:10.1093/mr/road081
BibTeX
@article{Sada2024,
author = {Sada, Ken-Ei and Nagasaka, Kenji and Kaname, Shinya and Nango, Eishu and Kishibe, Kan and Dobashi, Hiroaki and Hiromura, Keiju and Kawakami, Tamihiro and Bando, Masashi and Wada, Takashi and Amano, Koichi and Murakawa, Yohko and Harigai, Masayoshi},
title = {Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update – secondary publication},
journal = {Modern Rheumatology},
year = {2024},
volume = {34},
number = {3},
pages = {559--567},
doi = {10.1093/mr/road081}
}
EUVIMED